{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:36:13Z","timestamp":1743068173138},"reference-count":23,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.vaccine.2009.02.022","type":"journal-article","created":{"date-parts":[[2009,2,14]],"date-time":"2009-02-14T15:23:56Z","timestamp":1234625036000},"page":"2299-2305","source":"Crossref","is-referenced-by-count":10,"title":["Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants"],"prefix":"10.1016","volume":"27","author":[{"given":"Rosanna","family":"Lagos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.022_bib1","unstructured":"World Health Organization. Global immunization vision and strategy. April 2005. Available at: www.who.int\/vaccines\/GIVS\/english\/Global_imm._data_EN.pdf."},{"key":"10.1016\/j.vaccine.2009.02.022_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.022_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.022_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.022_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.022_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Gambian Pneumococcal Vaccine Trial Group Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.02.022_bib7","unstructured":"World Health Organization. WHO Technical Report Series: recommendations for the production and control of pneumococcal conjugate vaccines, No. 927. 2005; pp 66\u201398."},{"key":"10.1016\/j.vaccine.2009.02.022_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2009.02.022_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(90)90264-V","article-title":"An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay","volume":"135","author":"Phipps","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2009.02.022_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/CDLI.3.1.84-88.1996","article-title":"Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay","volume":"3","author":"Madore","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2009.02.022_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitides serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2009.02.022_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00006454-200211000-00006","article-title":"Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal vaccine in infants in Soweto, South Africa","volume":"21","author":"Huebner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2009.02.022_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.02.022_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.02.022_bib15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.02.022_bib16","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.02.022_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006454-199709000-00009","article-title":"Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis\/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.022_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00006454-199802000-00019","article-title":"Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers","volume":"17","author":"Rennels","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.022_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0264-410X(98)00162-5","article-title":"Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines","volume":"17","author":"Fattom","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.022_bib20","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/IAI.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.02.022_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/514063","article-title":"Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines","volume":"176","author":"Daum","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.022_bib22","unstructured":"Bryant KA, Block SL, Scott DA. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Presented at the 25th ESPID; May 4, 2007; Porto, Portugal."},{"key":"10.1016\/j.vaccine.2009.02.022_bib23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0900228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0900228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:47:27Z","timestamp":1589572047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0900228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":23,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0264410X0900228X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}